Abeona Therapeutics Inc.

ABEO

$5.45

Name : Abeona Therapeutics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $310,623,520.00

EPSttm : 0.96

Abeona Therapeutics Inc.

$5.45

1.30%

$0.07

ABEO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

28.87

Margin Of Safety %

Put/Call OI Ratio

0.33

EPS Next Q Diff

0.19

EPS Last/This Y

-2.02

EPS This/Next Y

0.97

Price

5.45

Target Price

19.71

Analyst Recom

Performance Q

6.03

Upside

503.7%

Beta

1.35

Ticker: ABEO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ABEO	5.87	0.35	0.41	31001
2026-05-12	ABEO	5.69	0.35	0.11	31234
2026-05-13	ABEO	5.72	0.35	0.02	31358
2026-05-14	ABEO	5.61	0.35	0.04	31537
2026-05-15	ABEO	5.49	0.35	0.78	31408
2026-05-18	ABEO	5.38	0.32	0.81	25889
2026-05-19	ABEO	5.13	0.32	0.57	25909
2026-05-20	ABEO	5.32	0.33	0.27	26062
2026-05-21	ABEO	5.52	0.32	0.00	26514
2026-05-22	ABEO	5.45	0.32	0.03	26503
2026-05-26	ABEO	5.5	0.33	0.01	26558
2026-05-27	ABEO	5.7	0.32	0.21	26726
2026-05-28	ABEO	5.79	0.33	5.69	26346
2026-05-29	ABEO	5.79	0.33	11.37	26312
2026-06-02	ABEO	5.7	0.33	0.80	26321
2026-06-03	ABEO	5.68	0.33	8.93	26356
2026-06-04	ABEO	5.81	0.33	0.36	26356
2026-06-05	ABEO	5.46	0.33	0.64	26366
2026-06-08	ABEO	5.39	0.33	0.13	26430
2026-06-09	ABEO	5.45	0.33	0.07	26271
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ABEO	5.87	-63.9	-	-0.91
2026-05-12	ABEO	5.69	-63.9	-	-0.91
2026-05-13	ABEO	5.73	-63.9	-	-0.91
2026-05-14	ABEO	5.61	-63.9	-	-0.91
2026-05-15	ABEO	5.50	-63.9	-	-0.91
2026-05-18	ABEO	5.38	37.9	-	-0.91
2026-05-19	ABEO	5.14	37.9	-	-0.91
2026-05-20	ABEO	5.32	37.9	-	-0.68
2026-05-21	ABEO	5.53	37.9	-	-0.68
2026-05-22	ABEO	5.45	50.0	-	-0.68
2026-05-26	ABEO	5.50	50.0	-	-0.68
2026-05-27	ABEO	5.70	50.0	-	-0.68
2026-05-28	ABEO	5.78	50.0	-	-0.68
2026-05-29	ABEO	5.80	50.0	-	-0.68
2026-06-01	ABEO	5.63	50.0	-	-0.68
2026-06-02	ABEO	5.70	50.0	-	-0.68
2026-06-03	ABEO	5.68	50.0	-	-0.68
2026-06-04	ABEO	5.81	50.0	-	-0.68
2026-06-05	ABEO	5.47	50.0	-	-0.68
2026-06-08	ABEO	5.39	50.0	-	-0.68
2026-06-09	ABEO	5.45	50.0	-	-0.68
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ABEO	-3.00	-2.02	34.09
2026-05-12	ABEO	-3.06	-2.02	34.12
2026-05-13	ABEO	-3.06	-2.02	34.12
2026-05-14	ABEO	-3.06	-2.02	34.12
2026-05-15	ABEO	-2.90	-2.02	34.12
2026-05-18	ABEO	-3.19	-2.20	34.27
2026-05-19	ABEO	-3.13	-2.20	34.20
2026-05-20	ABEO	-3.16	-2.20	34.20
2026-05-21	ABEO	-3.16	-2.20	32.90
2026-05-22	ABEO	-4.00	-2.20	32.90
2026-05-26	ABEO	-4.09	-3.50	32.90
2026-05-27	ABEO	-4.09	-3.50	32.90
2026-05-28	ABEO	-4.09	-3.50	28.87
2026-05-29	ABEO	-4.09	-3.50	28.87
2026-06-02	ABEO	-4.09	-4.30	28.87
2026-06-03	ABEO	-4.09	-4.30	28.87
2026-06-04	ABEO	-4.09	-4.30	28.87
2026-06-05	ABEO	-4.09	-4.30	28.87
2026-06-08	ABEO	-4.09	-4.30	28.87
2026-06-09	ABEO	-4.09	-4.30	28.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

-4.09

Institutional Transactions

-4.3

Beta

1.35

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

88.5

Max Drawdown 5-Year %

-95.1

Target Price

19.71

P/E

5.82

Forward P/E

PEG

P/S

21.36

P/B

2.14

P/Free Cash Flow

EPS

0.94

Average EPS Est. Cur. Y

-0.68

EPS Next Y. (Est.)

0.29

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

454.86

Relative Volume

0.97

Return on Equity vs Sector %

18.1

Return on Equity vs Industry %

34.3

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.22

EBIT Estimation

◆ ABEO Healthcare

$5.45

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

19/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

47.4

Range 1M

38.5%

Sup Dist

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

12/30

Estimates

3/20

Inst/Vol

2/15

Options

8/10

EPS Yr

-171.5%

EPS NY

91%

52W%

40.7%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +136.3% upside

Quality

25/30

Valuation

18/30

Growth

9/25

Stability

7/10

LT Trend

1/5

Upside

+136.3%

Quality

Abeona Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 226

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

ABEO

Latest News

—

Caricamento notizie per ABEO…

stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today

news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance

stock history ABEO – Abeona Therapeutics Inc invest stock market

stock prices ABEO premarket after hours

ticker ABEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y